These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 14280894)

  • 21. Expansion and retention of pulmonary CD4
    Roberts LM; Wehrly TD; Crane DD; Bosio CM
    Vaccine; 2017 May; 35(19):2575-2581. PubMed ID: 28372827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination strategies for Francisella tularensis.
    Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.
    Pammit MA; Raulie EK; Lauriano CM; Klose KE; Arulanandam BP
    Infect Immun; 2006 Apr; 74(4):2063-71. PubMed ID: 16552035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
    Griffin AJ; Crane DD; Wehrly TD; Bosio CM
    Clin Vaccine Immunol; 2015 Jan; 22(1):119-28. PubMed ID: 25410207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [PROBLEMS OF VACCINE PREVENTION OF TULAREMIA IN THE WORKS OF AMERICAN AUTHORS. (REVIEW OF THE LITERATURE)].
    LEBEDINSKII VA
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Oct; 40():140-2. PubMed ID: 14134921
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunogenicity of a new lot of Francisella tularensis live vaccine strain in human volunteers.
    Waag DM; Sandström G; England MJ; Williams JC
    FEMS Immunol Med Microbiol; 1996 Mar; 13(3):205-9. PubMed ID: 8861030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Case of allergic reaction to living tularemia vaccine].
    BELOSTOTSKAIA EN; MAKSIMOVA EB; MASHKILLEISON AL
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Jan; 1():97-8. PubMed ID: 14360676
    [No Abstract]   [Full Text] [Related]  

  • 28. [Serologic reactions in vaccinated and not vaccinated subjects against tularemia].
    MARTINEVSKII IL
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Apr; 4():67-70. PubMed ID: 14387224
    [No Abstract]   [Full Text] [Related]  

  • 29. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung.
    Bar-On L; Cohen H; Elia U; Rotem S; Bercovich-Kinori A; Bar-Haim E; Chitlaru T; Cohen O
    Vaccine; 2017 Dec; 35(50):7001-7009. PubMed ID: 29102170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological survey of tularemia among butchers and slaughterhouse workers in Iran.
    Esmaeili S; Esfandiari B; Maurin M; Gouya MM; Shirzadi MR; Amiri FB; Mostafavi E
    Trans R Soc Trop Med Hyg; 2014 Aug; 108(8):516-8. PubMed ID: 24942898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Investigations on living vaccine against tularemia. I. Mildly pathogenic of Bacterium tularense and their immunologic properties].
    SKRODZKI E; TOMASZUNAS S
    Przegl Epidemiol; 1955; 9(3):199-210. PubMed ID: 13310637
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia.
    Burke DS
    J Infect Dis; 1977 Jan; 135(1):55-60. PubMed ID: 833449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of basic factors in the external environment in the control of tularemia at the present time].
    Davidovich VF
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Aug; 50(8):9-15. PubMed ID: 4274105
    [No Abstract]   [Full Text] [Related]  

  • 34. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine.
    McMurry JA; Gregory SH; Moise L; Rivera D; Buus S; De Groot AS
    Vaccine; 2007 Apr; 25(16):3179-91. PubMed ID: 17291638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tularaemia vaccine.
    Sandström G
    J Chem Technol Biotechnol; 1994 Apr; 59(4):315-20. PubMed ID: 7764815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tularemia vaccines.
    Putzova D; Senitkova I; Stulik J
    Folia Microbiol (Praha); 2016 Nov; 61(6):495-504. PubMed ID: 27194547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characteristics of the tularemia prevention measures in the natural foci of the Carpathian region].
    Vetchinin VV; Sukhopiatkina AA; Bat OS; Potapova VG
    Vrach Delo; 1980 Jan; (1):107-9. PubMed ID: 7376572
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tularemia vaccine: past, present and future.
    Oyston PC; Quarry JE
    Antonie Van Leeuwenhoek; 2005 May; 87(4):277-81. PubMed ID: 15928980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.